Skip to main content
Log in

Development of LC–MS/MS Method for Simultaneous Determination of Irinotecan and Its Main Metabolites in Rat Plasma, and Its Application in Pharmacokinetic Studies

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

The anticancer agent irinotecan (CPT-11) is widely used in several cancer regimens. However, drug–drug interaction effects and considerable interindividual variability in the pharmacokinetics of CPT-11 and its metabolites have been observed, leading to side effects. To solve these problems and promote CPT-11 treatment, we established and validated a simple, rapid, and sensitive LC–MS/MS method for the simultaneous quantitative determination of CPT-11 and its main metabolites (SN-38, SN-38G, and APC). Protein precipitation with methanol was selected for sample preparation. All separations were performed on an Agilent ZORBAX Eclipse XDB-C18 column (2.1 × 50 mm, 3.5 μm) under isocratic elution with a mobile phase consisting of acetonitrile and 0.1% formic acid. The mass spectrometer was operated with multiple reaction monitoring in positive ion mode. The method was validated as linear over the concentration ranges 16.9–6760 ng mL−1 for CPT-11, 2.3–920 ng mL−1 for SN-38, 2.5–1000 ng mL−1 for SN-38G, and 1.25–250 ng mL−1 for APC. The intra- and interbatch precisions and accuracies of the validated method were within acceptable limits (<15%). This method was successfully applied to a pharmacokinetic study of CPT-11 and its main metabolites in rats.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Vanhoefer U, Harstrick A, Achterrath W, Cao S, Seeber S, Rustum YM (2001) J Clin Oncol 19:1501–1518

    CAS  Google Scholar 

  2. Newton KF, Newman W, Hill J (2012) Colorectal Dis 14:3–17

    Article  CAS  Google Scholar 

  3. Mathijssen RH, van Alphen RJ, Verweij J, Loos WJ, Nooter K, Stoter G, Sparreboom A (2001) Clin Cancer Res 7:2182–2194

    CAS  Google Scholar 

  4. Sai K, Kaniwa N, Ozawa S, Sawada JI (2001) Drug Metab Dispos 29:1505–1513

    CAS  Google Scholar 

  5. Innocenti F, Undevia SD, Iyer L, Chen PX, Das S, Kocherginsky M, Karrison T, Janisch L, Ramírez J, Rudin CM, Vokes EE, Ratain MJ (2004) J Clin Oncol 22:1382–1388

    Article  CAS  Google Scholar 

  6. Owens TS, Dodds H, Fricke K, Hanna SK, Crews KR (2003) J Chromatogr B 788:65–74

    Article  CAS  Google Scholar 

  7. de Jong FA, Mathijssen RH, de Bruijn P, Loos WJ, Verweij J, Sparreboom A (2003) J Chromatogr B 795:383–388

    Article  Google Scholar 

  8. Ramesh M, Ahlawat P, Srinivas NR (2010) Biomed Chromatogr 24:104–123

    Article  Google Scholar 

  9. Bardin S, Guo W, Johnson JL, Khan S, Ahmad A, Duggan JX, Ayoub J, Ahmad I (2005) J Chromatogr A 1073:249–255

    Article  CAS  Google Scholar 

  10. Zhang W, Dutschman GE, Li X, Ye M, Cheng YC (2009) J Chromatogr B 877:3038–3044

    Article  CAS  Google Scholar 

  11. Marangon E, Posocco B, Mazzega E, Toffoli G (2015) PLoS One 10:e118194

    Article  Google Scholar 

  12. Slatter JG, Schaaf LJ, Sams JP, Feenstra KL, Johnson MG, Bombardt PA, Cathcart KS, Verburg MT, Pearson LK, Compton LD, Miller LL, Baker DR, Peshek CV, Lord RS 3rd (2000) Drug Metab Dispos 28:423–433

    CAS  Google Scholar 

  13. D’Esposito F, Tattam BN, Ramzan I, Murray M (2008) J Chromatogr B 875:522–530

    Article  Google Scholar 

  14. US Department of Health and Human Services, US Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine (2001) Guidance for industry: bioanalytical method evaluation. http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf. Accessed 15 Oct 2013

  15. Yang X, Hu Z, Chan SY, Goh BC, Duan W, Chan E, Zhou S (2005) J Chromatogr B 821:221–228

  16. Basu S, Zeng M, Yin T, Gao S, Hu M (2016) J Chromatogr B 1015–1016:34–41

Download references

Acknowledgements

This study was financially supported by the National Natural Science Foundation of China (grants 81403012 and 81473287).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yongning Lu.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 301 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, N., Zhu, C., Zhai, X. et al. Development of LC–MS/MS Method for Simultaneous Determination of Irinotecan and Its Main Metabolites in Rat Plasma, and Its Application in Pharmacokinetic Studies. Chromatographia 80, 77–85 (2017). https://doi.org/10.1007/s10337-016-3207-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-016-3207-9

Keywords

Navigation